Cargando…
Impact of chronic fibrosing interstitial lung disease on healthcare use: association between fvc decline and inpatient hospitalization
BACKGROUND: Many types of interstitial lung diseases (ILDs) may transition to progressive chronic-fibrosing ILDs with rapid lung function decline and a negative survival prognosis. In real-world clinical settings, forced vital capacity (FVC) measures demonstrating progressive decline may be linked t...
Autores principales: | Singer, David, Chastek, Benjamin, Sargent, Andrew, Johnson, Jonathan C., Shetty, Sharash, Conoscenti, Craig, Bernstein, Elana J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492374/ https://www.ncbi.nlm.nih.gov/pubmed/37689630 http://dx.doi.org/10.1186/s12890-023-02637-8 |
Ejemplares similares
-
Burden of illness in progressive fibrosing interstitial lung disease
por: Singer, David, et al.
Publicado: (2022) -
Claims-based Prevalence of Disease Progression among Patients with Fibrosing Interstitial Lung Disease Other than Idiopathic Pulmonary Fibrosis in the United States
por: Singer, David, et al.
Publicado: (2022) -
The Role of Radiology in Progressive Fibrosing Interstitial Lung Disease
por: Abu Qubo, Ahmad, et al.
Publicado: (2022) -
Meta-Analysis of Effect of Nintedanib on Reducing FVC Decline Across Interstitial Lung Diseases
por: Bonella, Francesco, et al.
Publicado: (2022) -
Autoimmune Progressive Fibrosing Interstitial Lung Disease: Predictors of Fast Decline
por: Nagy, Alexandra, et al.
Publicado: (2021)